Design, synthesis and biological evaluation of MEK PROTACs.
PROTACs targeting degradation of MEK have been designed based on allosteric MEK inhibitors. Inhibition of the phos-phorylation of ERK1/2 was less effective with the PROTACs than a small molecule inhibitor, the best PROTACs, however, were more effective in inhibiting proliferation of A375 cells than an inhibitor.